Rick Wolfen's most recent trade in RxSight Inc was a trade of 1,489,805 Common Stock done . Disclosure was reported to the exchange on Aug. 3, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
RxSight Inc | Rick Wolfen | Director | 03 Aug 2021 | 1,489,805 | 1,762,074 | - | 0 | Common Stock | ||
RxSight Inc | Rick Wolfen | Director | 03 Aug 2021 | 398,810 | 0 | - | - | Series C Preferred Stock | ||
RxSight Inc | Rick Wolfen | Director | 03 Aug 2021 | 357,227 | 0 | - | - | Series G Preferred Stock | ||
RxSight Inc | Rick Wolfen | Director | 03 Aug 2021 | 246,054 | 0 | - | - | Series B Preferred Stock | ||
RxSight Inc | Rick Wolfen | Director | 03 Aug 2021 | 157,709 | 0 | - | - | Series H Preferred Stock | ||
RxSight Inc | Rick Wolfen | Director | 03 Aug 2021 | 154,886 | 0 | - | - | Series F Preferred Stock | ||
RxSight Inc | Rick Wolfen | Director | 03 Aug 2021 | 76,974 | 78,170 | - | 0 | Common Stock | ||
RxSight Inc | Rick Wolfen | Director | 03 Aug 2021 | 43,547 | 0 | - | - | Series D Preferred Stock | ||
RxSight Inc | Rick Wolfen | Director | 03 Aug 2021 | 42,552 | 0 | - | - | Series G Preferred Stock | ||
RxSight Inc | Rick Wolfen | Director | 03 Aug 2021 | 18,150 | 0 | - | - | Series E Preferred Stock | ||
RxSight Inc | Rick Wolfen | Director | 03 Aug 2021 | 11,714 | 0 | - | - | Series A Preferred Stock | ||
RxSight Inc | Rick Wolfen | Director | 03 Aug 2021 | 10,807 | 0 | - | - | Series D Preferred Stock | ||
RxSight Inc | Rick Wolfen | Director | 03 Aug 2021 | 9,680 | 0 | - | - | Series H Preferred Stock | ||
RxSight Inc | Rick Wolfen | Director | 03 Aug 2021 | 4,840 | 0 | - | - | Series E Preferred Stock | ||
RxSight Inc | Rick Wolfen | Director | 03 Aug 2021 | 2,800 | 0 | - | - | Series A Preferred Stock | ||
RxSight Inc | Rick Wolfen | Director | 03 Aug 2021 | 2,017 | 0 | - | - | Series B Preferred Stock | ||
RxSight Inc | Rick Wolfen | Director | 03 Aug 2021 | 1,452 | 0 | - | - | Series H Preferred Stock | ||
RxSight Inc | Rick Wolfen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2021 | 1,452 | 1,452 | - | - | Series H Preferred Stock | |
RxSight Inc | Rick Wolfen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2021 | 1,452 | 0 | - | - | Warrant (right to buy) |